WOLFGANG WINKELMAYER to Hypolipidemic Agents
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Hypolipidemic Agents.
Connection Strength
0.761
-
Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice. Heart. 2007 Aug; 93(8):945-51.
Score: 0.246
-
Comparative effectiveness of branded vs. generic versions of antihypertensive, lipid-lowering and hypoglycemic substances: a population-wide cohort study. Sci Rep. 2020 04 06; 10(1):5964.
Score: 0.152
-
Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study. Pharmacoepidemiol Drug Saf. 2016 Jan; 25(1):90-9.
Score: 0.112
-
Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort study. Appl Health Econ Health Policy. 2015 Apr; 13(2):193-205.
Score: 0.107
-
Medication issues in older individuals with CKD. Adv Chronic Kidney Dis. 2010 Jul; 17(4):320-8.
Score: 0.077
-
Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol. 2008 Apr 01; 51(13):1247-54.
Score: 0.066